Research progress of SARS-CoV-2 vaccine-related ocular adverse events
10.3980/j.issn.1672-5123.2024.6.17
- VernacularTitle:新型冠状病毒疫苗相关眼部病变的研究进展
- Author:
Yusheng ZHU
1
;
Tong WANG
1
;
Xiaodong CHEN
1
Author Information
1. Xi'an No.1 Hospital;the First Affiliated Hospital of Northwest University;Shaanxi Institute of Ophthalmology, Xi'an 710002, Shaanxi Province, China; Northwest University, Xi'an 710069, Shaanxi Province, China
- Publication Type:Journal Article
- Keywords:
severe acute respiratory syndrome coronavirus 2;
vaccine;
adverse events;
ocular symptoms
- From:
International Eye Science
2024;24(6):925-929
- CountryChina
- Language:Chinese
-
Abstract:
Since 2019, severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection has been widespread in the world, causing about 770 million infecting and 6.9 million deaths. Vaccines against SARS-CoV-2 infection have become the main way to prevent the severe SARS-CoV-2. The use of SARS-CoV-2 vaccine has substantial protection against the serious consequences of SARS-CoV-2 infection, but multiple systemic adverse reactions can occur after the use of SARS-CoV-2 vaccine. More and more studies have shown that SARS-CoV-2 vaccine caused lesions of ocular conjunctiva, cornea, sclera, uvea, retina and optic nerve tissue and resulted in damage to visual function. In this paper, the classification and characteristics of SARS-CoV-2 vaccines and related studies on ocular tissue lesions were reviewed, hoping to better understand the ocular adverse reactions of SARS-CoV-2 vaccine and provide some theoretical guidance for the prevention and treatment of ocular tissue damage caused by SARS-COV-2 vaccine.
